Cite
HARVARD Citation
Glimelius, B. et al. (2018). Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx®): a placebo-controlled randomised phase II study (PLIANT). Acta oncologica. pp. 393-402. [Online].